Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial

Autor: Naimi, Rahim M, Hvistendahl, Mark, Enevoldsen, Lotte H, Madsen, Jan L, Fuglsang, Stefan, Poulsen, Steen S, Kissow, Hannelouise, Pedersen, Jens, Nerup, Nikolaj, Ambrus, Rikard, Achiam, Michael P, Svendsen, Lars B, Holst, Jens J, Hartmann, Bolette, Hansen, Svend H, Dragsted, Lars O, Steensberg, Adam, Mouritzen, Ulrik, Hansen, Mark B, Jeppesen, Palle B
Zdroj: In The Lancet Gastroenterology & Hepatology May 2019 4(5):354-363
Databáze: ScienceDirect